Stracciari Andrea, Mattarozzi Katia, D'Alessandro Roberto, Baldin Elisa, Guarino Maria
Neurology Unit, S. Orsola-Malpighi University Hospital, via Albertoni 15, 40138, Bologna, Italy.
Metab Brain Dis. 2008 Jun;23(2):155-60. doi: 10.1007/s11011-008-9088-3. Epub 2008 Apr 24.
CNS involvement is frequent in patients with chronic liver disease, resulting in overt or subclinical ("minimal") encephalopathy. Occasionally, patients liver cirrhosis may develop a progressive encephalopathy known as chronic acquired hepatocerebral degeneration (CAHD), presenting with neuropsychiatric changes and movement disorders. In patients affected by CAHD cognitive dysfunction is the rule, but to date this aspect has not been systematically studied. Our aim was to characterize the neuropsychological profile of cognitive impairment associated with CAHD. Eight patients with CAHD received extensive neuropsychological assessment, far from episodes of acute liver decompensation. Their cognitive performances were compared with those of 8 patients with cirrhosis free from CAHD or overt hepatic encephalopathy (HE) and with those of 8 healthy controls matched for age, sex and educational level. Patients with CAHD revealed a significant impairment of visuo-spatial attention compared to healthy controls, and a lower performance on a single task of visual search and sequencing when compared to cirrhotics without CAHD. Our findings support the hypothesis of a linear decline in attentional performances of patients with chronic liver disease, starting from cognitively intact patients, moving toward patients with minimal HE, and finally progressing to those with overt HE and CAHD.
中枢神经系统受累在慢性肝病患者中很常见,可导致显性或亚临床(“轻微”)脑病。偶尔,肝硬化患者可能会发展为一种进行性脑病,称为慢性获得性肝脑变性(CAHD),表现为神经精神改变和运动障碍。在受CAHD影响的患者中,认知功能障碍是普遍现象,但迄今为止这方面尚未得到系统研究。我们的目的是描述与CAHD相关的认知障碍的神经心理学特征。八名CAHD患者接受了全面的神经心理学评估,评估时远离急性肝失代偿发作。将他们的认知表现与八名无CAHD或显性肝性脑病(HE)的肝硬化患者以及八名年龄、性别和教育水平相匹配的健康对照者的认知表现进行比较。与健康对照者相比,CAHD患者的视觉空间注意力有明显受损,与无CAHD的肝硬化患者相比,在视觉搜索和排序单项任务中的表现更低。我们的研究结果支持这样一种假设,即慢性肝病患者的注意力表现呈线性下降,从认知功能正常的患者开始,发展为轻微HE患者,最终进展为显性HE和CAHD患者。